Birchview Capital, LP
- SEC CIK
- 0001618205
- Latest filing
- Aug 14, 2026
Holdings in Q3 2022
Holdings as of Sep 30, 2022, filed Nov 28, 2022. Long positions only; changes compare share counts with Q2 2022.
- Positions
- 60
- 0 vs. Q2 2022
- Portfolio value
- $142.0M
- +$4.53M (+3.3%) vs. Q2 2022
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| BMYBristol Myers Squibb Co | Stock | 727,785 | $51.7M | 36.4% | 00.0% | Unchanged | History |
| ELUTElutia Inc. | CL A COM | 1,418,123 | $10.2M | 7.2% | 00.0% | Unchanged | History |
| NBIXNeurocrine Biosciences Inc | Stock | 85,240 | $9.05M | 6.4% | 00.0% | Unchanged | History |
| PRTAProthena Corp Public Ltd Co | SHS | 118,945 | $7.21M | 5.1% | +16,397+16.0% | Added | History |
| QDELQuidelOrtho Corp | COM | 61,306 | $4.38M | 3.1% | 00.0% | Unchanged | History |
| ACADAcadia Pharmaceuticals Inc | COM | 249,400 | $4.08M | 2.9% | 00.0% | Unchanged | History |
| OVVOvintiv Inc. | COM | 84,200 | $3.87M | 2.7% | 00.0% | Unchanged | History |
| AXDXAccelerate Diagnostics, Inc | COM | 2,252,388 | $3.42M | 2.4% | 00.0% | Unchanged | History |
| UTHRUnited Therapeutics Corp | COM | 15,000 | $3.14M | 2.2% | 00.0% | Unchanged | History |
| BDSXBiodesix Inc | COM | 2,370,071 | $3.01M | 2.1% | +558,659+30.8% | Added | History |
| CLRContinental Resources, Inc | COM | 38,600 | $2.58M | 1.8% | 00.0% | Unchanged | History |
| FHTXFoghorn Therapeutics Inc. | COM | 264,843 | $2.27M | 1.6% | −20,000−7.0% | Reduced | History |
| ALBOAlbireo Pharma, Inc. | COM | 117,000 | $2.27M | 1.6% | +4,000+3.5% | Added | History |
| BHVNBiohaven Ltd. | COM | 14,730 | $2.23M | 1.6% | −270−1.8% | Reduced | History |
| HROWHarrow, Inc. | COM | 180,000 | $2.17M | 1.5% | 00.0% | Unchanged | History |
| MASIMasimo Corp | COM | 15,280 | $2.16M | 1.5% | 00.0% | Unchanged | History |
| PHRPhreesia, Inc. | COM | 82,700 | $2.11M | 1.5% | 00.0% | Unchanged | History |
| GOSSGossamer Bio, Inc. | COM | 159,088 | $1.91M | 1.3% | 00.0% | Unchanged | History |
| VTYXVentyx Biosciences, Inc. | COM | 45,000 | $1.57M | 1.1% | +12,000+36.4% | Added | History |
| KPTIKaryopharm Therapeutics Inc. | COM | 269,332 | $1.47M | 1.0% | 00.0% | Unchanged | History |
| CORTCorcept Therapeutics Inc | COM | 50,000 | $1.28M | 0.9% | 00.0% | Unchanged | History |
| INBXInhibrx Biosciences, Inc. | COM | 70,448 | $1.26M | 0.9% | 00.0% | Unchanged | History |
| CYTKCytokinetics Inc | COM NEW | 25,000 | $1.21M | 0.9% | 00.0% | Unchanged | History |
| AVEOAveo Pharmaceuticals, Inc. | COM NEW | 140,000 | $1.15M | 0.8% | 00.0% | Unchanged | History |
| ALKSAlkermes plc. | SHS | 50,000 | $1.12M | 0.8% | 00.0% | Unchanged | History |
| DCGODocGo Inc. | COM | 110,000 | $1.09M | 0.8% | 00.0% | Unchanged | History |
| ChemoCentryx, Inc.16383L106 | COM | 20,000 | $1.03M | 0.7% | 00.0% | Unchanged | – |
| ETRNMidstream Co LLC | COM | 133,050 | $995.0K | 0.7% | 00.0% | Unchanged | History |
| TSVT2seventy bio, Inc. | COMMON STOCK | 59,833 | $871.0K | 0.6% | 00.0% | Unchanged | History |
| PXDPioneer Natural Resources Co | COM | 3,800 | $823.0K | 0.6% | 00.0% | Unchanged | History |
| APLSApellis Pharmaceuticals, Inc. | COM | 12,000 | $820.0K | 0.6% | 00.0% | Unchanged | History |
| NARIInari Medical, Inc. | Stock | 10,000 | $726.0K | 0.5% | 00.0% | Unchanged | History |
| IMGNImmunoGen, Inc. | COM | 150,000 | $717.0K | 0.5% | 00.0% | Unchanged | History |
| ARVNArvinas, Inc. | COM | 15,000 | $667.0K | 0.5% | 00.0% | Unchanged | History |
| BLUEbluebird bio, Inc. | COM | 98,000 | $620.0K | 0.4% | 00.0% | Unchanged | History |
| KALVKalVista Pharmaceuticals, Inc. | COM | 40,000 | $580.0K | 0.4% | 00.0% | Unchanged | History |
| IRTCiRhythm Holdings, Inc. | COM | 4,000 | $501.0K | 0.4% | 00.0% | Unchanged | History |
| GTHXG1 Therapeutics, Inc. | COM | 40,000 | $500.0K | 0.4% | 00.0% | Unchanged | History |
| SILKSilk Road Medical Inc | COM | 10,000 | $450.0K | 0.3% | 00.0% | Unchanged | History |
| ISEEIVERIC bio, Inc. | COM | 25,000 | $449.0K | 0.3% | +10,000+66.7% | Added | History |
| NKTRNektar Therapeutics | COM | 128,000 | $410.0K | 0.3% | 00.0% | Unchanged | History |
| SLNOSoleno Therapeutics Inc | COM | 245,127 | $409.0K | 0.3% | 00.0% | UnchangedConverted for a 1-for-15 split | History |
| FOLDAmicus Therapeutics, Inc. | COM | 38,000 | $397.0K | 0.3% | 00.0% | Unchanged | History |
| KNSAKiniksa Pharmaceuticals International, plc | COM CL A | 30,000 | $385.0K | 0.3% | 00.0% | Unchanged | History |
| XENEXenon Pharmaceuticals Inc. | COM | 10,000 | $361.0K | 0.3% | 00.0% | Unchanged | History |
| CGEMCullinan Therapeutics, Inc. | COM | 25,114 | $322.0K | 0.2% | −20,000−44.3% | Reduced | History |
| PTGXProtagonist Therapeutics, Inc | COM | 38,000 | $320.0K | 0.2% | 00.0% | Unchanged | History |
| XNCRXencor Inc | COM | 12,300 | $320.0K | 0.2% | 00.0% | Unchanged | History |
| SRPTSarepta Therapeutics, Inc. | COM | 2,500 | $276.0K | 0.2% | +2,500 | New | History |
| BCRXBiocryst Pharmaceuticals Inc | COM | 20,000 | $252.0K | 0.2% | 00.0% | Unchanged | History |
| STOKStoke Therapeutics, Inc. | COM | 15,000 | $193.0K | 0.1% | 00.0% | Unchanged | History |
| IFRXInflaRx N.V. | COM | 70,000 | $185.0K | 0.1% | 00.0% | Unchanged | History |
| CNCEConcert Pharmaceuticals, Inc. | COM | 20,000 | $134.0K | 0.1% | 00.0% | Unchanged | History |
| ATECAlphatec Holdings, Inc. | COM NEW | 10,000 | $87.0K | 0.1% | +10,000 | New | History |
| YTENYIELD10 Bioscience, Inc. | COM | 18,750 | $56.0K | <0.1% | 00.0% | Unchanged | History |
| LSFLaird Superfood, Inc. | COM STK | 28,000 | $51.0K | <0.1% | 00.0% | Unchanged | History |
| ELTXElicio Therapeutics, Inc. | COM | 54,392 | $50.0K | <0.1% | 00.0% | Unchanged | History |
| CFRXCONTRAFECT Corp | COM | 200,000 | $34.0K | <0.1% | 00.0% | Unchanged | History |
| SIENProject Sage Oldco, Inc. | COM | 40,000 | $26.0K | <0.1% | 00.0% | Unchanged | History |
| AWHLAspira Women's Health Inc. | COM | 60,070 | $22.0K | <0.1% | −23,034−27.7% | Reduced | History |
Sold out since Q2 2022 (2)
Positions held at the end of Q2 2022 that are gone from this filing.